about
Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cellsSIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylationThe mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenaseLoss of PINK1 attenuates HIF-1α induction by preventing 4E-BP1-dependent switch in protein translation under hypoxiaMetabolism of kidney cancer: from the lab to clinical practiceApplications of metabolomics in cancer researchMammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growthLinks between metabolism and cancerInsights into the Regulatory Role of Non-coding RNAs in Cancer MetabolismClinical significance of T cell metabolic reprogramming in cancerMicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancersMicroRNA in Metabolic Re-Programming and Their Role in TumorigenesisMitochondrial metabolic remodeling in response to genetic and environmental perturbationsDNA Tumor Viruses and Cell MetabolismClinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinomaMathematical models of cancer metabolismReactive oxygen species, nutrition, hypoxia and diseases: Problems solved?Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implicationSuccinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and EpigeneticsProgress toward overcoming hypoxia-induced resistance to solid tumor therapyRegulating the Intersection of Metabolism and Pathogenesis in Gram-positive BacteriaHypoxia signaling pathways: modulators of oxygen-related organellesAscorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progressionPyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and CancersCancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapiesImaging mitochondrial redox potential and its possible link to tumor metastatic potentialInterplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogrammingHow does the metabolism of tumour cells differ from that of normal cellsCancer cell metabolism: implications for therapeutic targetsImmunometabolism in TuberculosisThe Warburg effect revisited--lesson from the Sertoli cellHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionO-GlcNAcylation and Metabolic Reprograming in CancerAllosteric inhibition of hypoxia inducible factor-2 with small moleculesReexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effectDiscovery of cytoglobin and its roles in physiology and pathology of hepatic stellate cellsHypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symportersArginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathwayA strategically designed small molecule attacks alpha-ketoglutarate dehydrogenase in tumor cells through a redox processEnergy metabolism in H460 lung cancer cells: effects of histone deacetylase inhibitors
P2860
Q21133953-551704D6-4992-4A70-9730-547C62E868CEQ24293305-D6F81AF6-0408-4F21-8734-8860C4871646Q24294745-155BE13F-31FD-4FCF-A3D2-AB4B0B925DEAQ24337840-32E09465-C7AD-4962-9285-2CE4FA5E4127Q24600512-EDFB1537-797A-4590-93CF-4399CB55222FQ24600728-5AED1C8A-42C3-448B-A364-5E22CFA7500BQ24603549-4387A025-219F-4E14-9C19-2C8A41F682F4Q24626229-5B7930DE-D4D3-4E18-B49F-7691C8F6B812Q26739857-E3A470E9-BF46-47A5-87A8-FB99C80C0225Q26741974-4FD4F52C-711E-4A08-AAF8-70A022D4ACF9Q26745980-7E497903-F738-42F7-8D74-EE4DDAB80D60Q26746958-90E5E9D0-850C-4A98-883E-BFB990D2F1FDQ26747718-EB9F5568-F3F6-4065-8AA9-2B0632E7B631Q26749066-EF0D8CF5-30E9-4F5D-B72F-85B841FD41B1Q26752515-9333AE73-D608-49E2-9F67-75A24B2EA17CQ26772067-23D9CED7-B57F-4FB1-80BF-5CF0C1E8F6B1Q26784413-134698C5-C02C-4DF3-BBEF-9572A91BE38FQ26795759-3009A179-D118-49C2-A8F4-2AEEB164108CQ26796203-890DF24A-40FF-4C84-824A-CB61E5F64D15Q26796405-7A7E6358-FB35-4D03-9C18-814E908D25F2Q26799806-7BAF5066-6C9B-4714-A6D9-2DFF1C8B3503Q26799950-C0DB460A-7327-45E9-A676-D5B004533FB4Q26822640-88BD7F60-7CCA-4EE6-BA57-F4ABF3E4A8BFQ26822845-FC3A6C5B-9E0A-4163-8AB0-A745D22B0C0DQ26823118-12C8653D-5EC3-498E-9053-88DEA76E5CADQ26825824-F4A2005B-0877-4F48-B6C5-A603174CF487Q26991931-FF1E3F52-FD18-483E-A7BC-6A22EC8B83B3Q27011856-516CEC2A-137B-4683-9325-6B38A9144CA3Q27013632-5676B358-3990-4D1E-8FFF-D0F408BF2B1AQ27021247-FB9A2ADF-199E-438E-8B20-B477333F6F63Q27025749-FD1F62A0-94FF-493C-B9DF-F67048019D7BQ27025886-03F262B7-4127-4889-8B4A-71519D313D5FQ27027028-BF3B14B4-B385-4D17-B3B0-A3DAA763D08BQ27676596-C0FB2F03-A2BB-4CFF-8C65-96C7BF27838CQ28077883-DC52A0F8-707B-4E77-ACFC-C621EE2D2ACCQ28077936-332E48C3-7CB5-491D-94CF-7F5ED1B85C28Q28081811-25A4C4E4-7744-4A4C-AE93-A107F35B395AQ28388238-49AE401F-FD98-4045-B7C1-F5D00BC1D90EQ28390796-A29B339D-00EE-44EB-AAF6-71E0ECF4295BQ28479066-D39C6D9B-5C19-42F3-81D7-8505F6CE7E35
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
HIF-1: upstream and downstream of cancer metabolism
@ast
HIF-1: upstream and downstream of cancer metabolism
@en
HIF-1: upstream and downstream of cancer metabolism
@nl
type
label
HIF-1: upstream and downstream of cancer metabolism
@ast
HIF-1: upstream and downstream of cancer metabolism
@en
HIF-1: upstream and downstream of cancer metabolism
@nl
prefLabel
HIF-1: upstream and downstream of cancer metabolism
@ast
HIF-1: upstream and downstream of cancer metabolism
@en
HIF-1: upstream and downstream of cancer metabolism
@nl
P2860
P3181
P1476
HIF-1: upstream and downstream of cancer metabolism
@en
P2860
P3181
P356
10.1016/J.GDE.2009.10.009
P407
P577
2010-02-01T00:00:00Z